LITSHealthcare · Biotechnology

LITS Stock Forecast: Lite Strategy, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$1.10

+3.77% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 12 Sept 2026 — in the lower half.

Market cap

$37.4M

Ticker Nerd rank

31 / 100

Median analyst target

—

Analysts covering

—

Revenue$0.0

Operating income−$2.8M

Net income−$23.7M

Free cash flow−$1.5M

Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown

Total return, dividends reinvested

+5.8%

+22.2%

YTD

−16.7%

−65.3%

From 52W high

−65.3%

From 52W low

+48.6%

$0.74

$3.17

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

LITS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Lite Strategy, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility

Growth

Size

Accruals

Quality

Issuance

Revisions

Value

Momentum

Volatility (86): The share price has been relatively steady.

Momentum (6): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

LITS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on LITS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. LITS appears on the weeks it earns a place.

Performance

LITS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Lite Strategy, Inc. returned −65.3% against +17.5% for the S&P 500, dividends included.

LITS vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

LITS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Lite Strategy, Inc. (LITS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.5×
Price / sales: —
Price / book: 0.7×
EV / EBITDA: −1.8×

Growth & margins

Revenue growth (YoY): —
Earnings growth (YoY): —
Gross margin: —
Operating margin: 0.0%
Net margin: 0.0%

Returns & dividend

Return on equity: −159.3%
Return on assets: −27.7%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Lite Strategy, Inc. (LITS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Lite Strategy, Inc. has a market value of $37.4M and an enterprise value of $30.1M.
Revenue in the twelve months to 31 Mar 2026: $0.0.
Net income over the same four quarters: −$60.8M.
Free cash flow in the twelve months to 31 Mar 2026: −$10.4M, after $0.0 of capital spending.
Shares outstanding: 35.2M.
Trailing P/E: −0.5×.
Lite Strategy, Inc. employs 4 people.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

LITS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology

Company	Market cap	TKN rank
LITSLite Strategy, Inc.	$37.4M	31
CELUCelularity, Inc.	$39.9M	19
CRVOCervoMed, Inc.	$38.9M	29
VERUVeru, Inc.	$41.6M	34
FLNAFilana Therapeutics, Inc.	$37.3M	59
ATYRaTyr Pharma, Inc.	$42.2M	49
KPTIKaryopharm Therapeutics, Inc.	$36.3M	56

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Lite Strategy, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest LITS news & analysis

Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York

GlobeNewsWire · 10 Sept 2026neutral

Lite Strategy, Inc. announced that members of its leadership team will present and host one-on-one investor meetings at the 28th Annual H.C. Wainwright Global Investment Conference in New York. The announcement was made via GlobeNewsWire on September 10, 2026.

Why it matters — The company's participation offers investors an opportunity to hear directly from Lite Strategy leadership at a major investment conference, providing visibility into the firm.

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

GlobeNewsWire · 30 July 2026positive

Lite Strategy repurchased approximately 4.9 million shares, or 13% of its outstanding shares, under its Share Repurchase Program between December 2025 and July 17, 2026, deploying about $5.4 million at an average price of $1.11 per share through treasury operations.

Why it matters — A LITS watcher would care because the buyback reduces the total share count, increasing the amount of Litecoin backing each remaining share.

FAQ

Frequently asked questions about LITS stock

How does Ticker Nerd's model rank LITS?

As at 12 Sept 2026, Lite Strategy, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (86 of 100).

What is the LITS stock forecast for 2030?

No analyst covering Lite Strategy, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LITS are extrapolating price history, which says nothing about the business.

How has LITS stock performed over the past year?

Lite Strategy, Inc. returned -65.3% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Lite Strategy, Inc. do?

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.

What is the latest news on LITS?

The most recent item we track (GlobeNewsWire, 10 Sept 2026): "Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York". Lite Strategy, Inc. announced that members of its leadership team will present and host one-on-one investor meetings at the 28th Annual H.C. Wainwright Global Investment Conference in New York. The announcement was made via GlobeNewsWire on September 10, 2026.

Company

About Lite Strategy, Inc.

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

CEO Mr. Justin J. File CPA · 4 employees · United States · https://www.litestrategy.com